In Australia, over 200,000 people live with epilepsy, a chronic neurological condition that is often characterised by seizures. Thousands are…
Biopharmaceuticals manufacturer MGC Pharmaceuticals (ASX: MXC) has seen significant uptake of its cannabinoid medications with prescriptions across Australia and the…